A citation-based method for searching scientific literature

Junko Kunieda, Kyoko Yamashita, Yuki Togashi, Satoko Baba, Seiji Sakata, Kentaro Inamura, Keisuke Ae, Seiichi Matsumoto, Rikuo Machinami, Masanobu Kitagawa, Kengo Takeuchi. Cancer Sci 2022
Times Cited: 4







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
50

TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
Christian Koelsche, Marcus Renner, Wolfgang Hartmann, Regine Brandt, Burkhard Lehner, Nina Waldburger, Ingo Alldinger, Thomas Schmitt, Gerlinde Egerer, Roland Penzel,[...]. J Exp Clin Cancer Res 2014
58
50

Telomerase Reverse Transcriptase Promoter Mutations in Human Hepatobiliary, Pancreatic and Gastrointestinal Cancer Cell Lines.
Masahiro Hirata, Koji Fujita, Shintaro Fujihara, Takaaki Mizuo, Ryota Nakabayashi, Toshiaki Kono, Daisuke Namima, Naoki Fujita, Hiroki Yamana, Hideki Kamada,[...]. In Vivo 2022
2
100

The RNA component of human telomerase.
J Feng, W D Funk, S S Wang, S L Weinrich, A A Avilion, C P Chiu, R R Adams, E Chang, R C Allsopp, J Yu. Science 1995
25

Presence of TERT Promoter Mutations is a Secondary Event and Associates with Elongated Telomere Length in Myxoid Liposarcomas.
Monica S Ventura Ferreira, Martina Crysandt, Till Braunschweig, Edgar Jost, Barbara Voss, Anne-Sophie Bouillon, Ruth Knuechel, Tim H Brümmendorf, Fabian Beier. Int J Mol Sci 2018
8
25

High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.
Jeffrey S Dome, Carol A Bockhold, Sierra M Li, Scott D Baker, Daniel M Green, Elizabeth J Perlman, D Ashley Hill, Norman E Breslow. J Clin Oncol 2005
43
25

TERT promoter mutations in soft tissue sarcomas.
Nathália C Campanella, Valter Penna, Lucas Faria Abrahão-Machado, Adriana Cruvinel-Carloni, Guilherme Ribeiro, Paula Soares, Cristovam Scapulatempo-Neto, Rui M Reis. Int J Biol Markers 2016
11
25

Telomere length variations in 6 mucosal cell types of gastric tissue observed using a novel quantitative fluorescence in situ hybridization method.
Junko Aida, Naotaka Izumiyama-Shimomura, Ken-Ichi Nakamura, Akio Ishii, Naoshi Ishikawa, Naoko Honma, Rie Kurabayashi, Makoto Kammori, Steven S S Poon, Tomio Arai,[...]. Hum Pathol 2007
40
25


Liposarcoma: molecular genetics and therapeutics.
Rachel Conyers, Sophie Young, David M Thomas. Sarcoma 2011
102
25

Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L Roncaioli, Frederik Sand, Johannes M Heuckmann,[...]. Nature 2015
325
25

Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression.
Aurora Costa, Maria Grazia Daidone, Laura Daprai, Raffaella Villa, Sabrina Cantù, Silvana Pilotti, Luigi Mariani, Alessandro Gronchi, Jeremy D Henson, Roger R Reddel,[...]. Cancer Res 2006
100
25



Alternative lengthening of telomeres: models, mechanisms and implications.
Anthony J Cesare, Roger R Reddel. Nat Rev Genet 2010
610
25

Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
Yoshinao Oda, Hidetaka Yamamoto, Tomonari Takahira, Chikashi Kobayashi, Kenichi Kawaguchi, Naomi Tateishi, Yoko Nozuka, Sadafumi Tamiya, Kazuhiro Tanaka, Shuichi Matsuda,[...]. J Pathol 2005
48
25

Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining.
Alan K Meeker, Wesley R Gage, Jessica L Hicks, Inpakala Simon, Jonathan R Coffman, Elizabeth A Platz, Gerrun E March, Angelo M De Marzo. Am J Pathol 2002
166
25

Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
Christopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, Michael G Goggins, Elizabeth A Montgomery, Edward Gabrielson, George J Netto, Jonathan I Epstein, Tamara L Lotan, William H Westra,[...]. Am J Pathol 2011
313
25

Recurrent TRIO Fusion in Nontranslocation-Related Sarcomas.
Lucile Delespaul, Tom Lesluyes, Gaëlle Pérot, Céline Brulard, Lydia Lartigue, Jessica Baud, Pauline Lagarde, Sophie Le Guellec, Agnès Neuville, Philippe Terrier,[...]. Clin Cancer Res 2017
25
25

High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.
J S Dome, S Chung, T Bergemann, C B Umbricht, M Saji, L A Carey, P E Grundy, E J Perlman, N E Breslow, S Sukumar. Cancer Res 1999
87
25

Cancer-testis antigens PRAME and NY-ESO-1 correlate with tumour grade and poor prognosis in myxoid liposarcoma.
Kunio Iura, Kenichi Kohashi, Yuka Hotokebuchi, Takeaki Ishii, Akira Maekawa, Yuichi Yamada, Hidetaka Yamamoto, Yukihide Iwamoto, Yoshinao Oda. J Pathol Clin Res 2015
43
25

Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas.
Akira Maekawa, Kenichi Kohashi, Masaaki Kuda, Kunio Iura, Takeaki Ishii, Makoto Endo, Tetsuya Nakatsura, Yukihide Iwamoto, Yoshinao Oda. BMC Cancer 2016
14
25


TERT promoter mutations are rare in bone and soft tissue sarcomas of Japanese patients.
Tsuyoshi Saito, Keisuke Akaike, Aiko Kurisaki-Arakawa, Midori Toda-Ishii, Kenta Mukaihara, Yoshiyuki Suehara, Tatsuya Takagi, Kazuo Kaneko, Takashi Yao. Mol Clin Oncol 2016
15
25

Telomerase promoter mutations in cancer: an emerging molecular biomarker?
João Vinagre, Vasco Pinto, Ricardo Celestino, Marta Reis, Helena Pópulo, Paula Boaventura, Miguel Melo, Telmo Catarino, Jorge Lima, José Manuel Lopes,[...]. Virchows Arch 2014
79
25

Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation.
Dong-Sheng Huang, Zhaohui Wang, Xu-Jun He, Bill H Diplas, Rui Yang, Patrick J Killela, Qun Meng, Zai-Yuan Ye, Wei Wang, Xiao-Ting Jiang,[...]. Eur J Cancer 2015
109
25

Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
K Perrem, L M Colgin, A A Neumann, T R Yeager, R R Reddel. Mol Cell Biol 2001
197
25

TERT Promoter Mutation and Extent of Thyroidectomy in Patients with 1-4 cm Intrathyroidal Papillary Carcinoma.
Aya Ebina, Yuki Togashi, Satoko Baba, Yukiko Sato, Seiji Sakata, Masashi Ishikawa, Hiroki Mitani, Kengo Takeuchi, Iwao Sugitani. Cancers (Basel) 2020
3
33


Activation status of receptor tyrosine kinase downstream pathways in primary lung adenocarcinoma with reference of KRAS and EGFR mutations.
Miyako Hiramatsu, Hironori Ninomiya, Kentaro Inamura, Kimie Nomura, Kengo Takeuchi, Yukitoshi Satoh, Sakae Okumura, Ken Nakagawa, Takao Yamori, Masaaki Matsuura,[...]. Lung Cancer 2010
36
25

Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Floris P Barthel, Wei Wei, Ming Tang, Emmanuel Martinez-Ledesma, Xin Hu, Samirkumar B Amin, Kadir C Akdemir, Sahil Seth, Xingzhi Song, Qianghu Wang,[...]. Nat Genet 2017
270
25

Telomerase catalytic subunit homologs from fission yeast and human.
T M Nakamura, G B Morin, K B Chapman, S L Weinrich, W H Andrews, J Lingner, C B Harley, T R Cech. Science 1997
25

Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
Courtney A Lovejoy, Wendi Li, Steven Reisenweber, Supawat Thongthip, Joanne Bruno, Titia de Lange, Saurav De, John H J Petrini, Patricia A Sung, Maria Jasin,[...]. PLoS Genet 2012
372
25

Altered telomeres in tumors with ATRX and DAXX mutations.
Christopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar,[...]. Science 2011
684
25

Telomere Maintenance Mechanisms in Cancer.
Tiago Bordeira Gaspar, Ana Sá, José Manuel Lopes, Manuel Sobrinho-Simões, Paula Soares, João Vinagre. Genes (Basel) 2018
55
25


The role of telomere biology in cancer.
Lifeng Xu, Shang Li, Bradley A Stohr. Annu Rev Pathol 2013
98
25

TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors.
Linda J Valentijn, Jan Koster, Danny A Zwijnenburg, Nancy E Hasselt, Peter van Sluis, Richard Volckmann, Max M van Noesel, Rani E George, Godelieve A M Tytgat, Jan J Molenaar,[...]. Nat Genet 2015
218
25

Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas.
Jen-Chieh Lee, Yung-Ming Jeng, Jau-Yu Liau, Jia-Huei Tsai, Hung-Han Hsu, Ching-Yao Yang. Mod Pathol 2015
34
25

Novel CTNND2-TERT fusion in a spindle cell liposarcoma.
Michael Occidental, Guomiao Shen, Xiaojun Feng, Kelsey Zhu, Kevin Kelly, Qian Nie, Honey V Reddi, Eleftheria Lakiotaki, Nora Athina Viniou, Penelope Korkolopoulou,[...]. Genes Chromosomes Cancer 2020
6
25

Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism.
Kunitoshi Chiba, Franziska K Lorbeer, A Hunter Shain, David T McSwiggen, Eva Schruf, Areum Oh, Jekwan Ryu, Xavier Darzacq, Boris C Bastian, Dirk Hockemeyer. Science 2017
148
25

Spindle cell liposarcoma with a TRIO-TERT fusion transcript.
David I Suster, Vikram Deshpande, Ivan Chebib, Martin S Taylor, John Mullen, Miriam A Bredella, G Petur Nielsen. Virchows Arch 2019
7
25

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
923
25

Expression of FUS-CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formation.
Rene Rodriguez, Juan Tornin, Carlos Suarez, Aurora Astudillo, Ruth Rubio, Carole Yauk, Andrew Williams, Michael Rosu-Myles, Juan M Funes, Chris Boshoff,[...]. Stem Cells 2013
51
25

FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells.
Rene Rodriguez, Ruth Rubio, Ivan Gutierrez-Aranda, Gustavo J Melen, Carolina Elosua, Javier García-Castro, Pablo Menendez. Stem Cells 2011
53
25

Telomerase activity in human germline and embryonic tissues and cells.
W E Wright, M A Piatyszek, W E Rainey, W Byrd, J W Shay. Dev Genet 1996
974
25

Revisiting Telomere Shortening in Cancer.
Keiji Okamoto, Hiroyuki Seimiya. Cells 2019
58
25


Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.
Sumit Borah, Linghe Xi, Arthur J Zaug, Natasha M Powell, Garrett M Dancik, Scott B Cohen, James C Costello, Dan Theodorescu, Thomas R Cech. Science 2015
207
25

TERT structural rearrangements in metastatic pheochromocytomas.
Trisha Dwight, Aidan Flynn, Kaushalya Amarasinghe, Diana E Benn, Richard Lupat, Jason Li, Daniel L Cameron, Annette Hogg, Shiva Balachander, Ida L M Candiloro,[...]. Endocr Relat Cancer 2018
35
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.